MENU
NVCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NovoCure (NVCR) Ownership - Who owns NovoCure?

NovoCure Ltd is an oncology company with a propreitary platform technology in United States... Show more

Profile

Industry
Medical Specialties
Address
Grenville Street
Phone
+44 1534756700
Employees
1453
Web
https://www.novocure.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
1.28B
P/E Ratio
N/A
Total Cash
1.03B
Projected Growth
N/A
Total Debt
797.94M
Revenue
642.27M
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash/Share
9.23
Total Debt/Equity
N/A
Revenue/Share
5.81 USD as % of share price

Fundamentals

NVCR
Capitalization
1.28B
P/E Ratio
N/A
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash
1.03B
Total Cash/Share
9.23
Total Debt
798M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.81%
Revenue
642M
ROE
N/A
Book Value
341M
P/B Ratio
3.76
Cash Flow
N/A
Earnings
-1.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
1.55
Current Revenue Per Employee
112368.28
Dividends Per Share - Security
N/A
EBITDA
-113.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
73.25
Revenue To Assets
-13.75
Shares Held By Institutions
4.39B
Shares Outstanding - Current
112M
Total Liabilities
1.02B
Total Volume MTD
N/A
Value
-1
Gain YTD
-61.544
View a ticker or compare two or three
NVCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVCR showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a commercial-stage oncology company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
Grenville Street
Phone
+44 1534756700
Employees
1453
Web
https://www.novocure.com